D.E. Shaw & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $65.4M | Buy |
|
|||||
|
2025
Q2 | $24M | Sell |
|
|||||
|
2025
Q1 | $46.3M | Sell |
|
|||||
|
2024
Q4 | $76.5M | Sell |
|
|||||
|
2024
Q3 | $80.6M | Sell |
|
|||||
|
2024
Q2 | $102M | Buy |
|
|||||
|
2024
Q1 | $39.7M | Sell |
|
|||||
|
2023
Q4 | $226M | Buy |
|
|||||
|
2023
Q3 | $211M | Buy |
|
|||||
|
2023
Q2 | $77.3M | Buy |
|
|||||
|
2023
Q1 | $52.2M | Sell |
|
|||||
|
2022
Q4 | $60.5M | Buy |
|
|||||
|
2022
Q3 | $31.4M | Sell |
|
|||||
|
2022
Q2 | $56.8M | Sell |
|
|||||
|
2022
Q1 | $91.9M | Sell |
|
|||||
|
2021
Q4 | $97M | Buy |
|
|||||
|
2021
Q3 | $19.7M | Buy |
|
|||||
|
2021
Q2 | $6.27M | Sell |
|
|||||
|
2021
Q1 | $16.2M | Sell |
|
|||||
|
2020
Q4 | $18.6M | Buy |
|
|||||
|
2020
Q3 | $9.52M | Sell |
|
|||||
|
2020
Q2 | $84.4M | Buy |
|
|||||
|
2020
Q1 | $36.5M | Buy |
|
|||||
|
2019
Q4 | $13.3M | Sell |
|
|||||
|
2019
Q3 | $51.6M | Sell |
|
|||||
|
2019
Q2 | $74.6M | Sell |
|
|||||
|
2019
Q1 | $177M | Sell |
|
|||||
|
2018
Q4 | $618M | Buy |
|
|||||
|
2018
Q3 | $734M | Sell |
|
|||||
|
2018
Q2 | $721M | Buy |
|
|||||
|
2018
Q1 | $485M | Buy |
|
|||||
|
2017
Q4 | $280M | Buy |
|
|||||
|
2017
Q3 | $153M | Sell |
|
|||||
|
2017
Q2 | $203M | Buy |
|
|||||
|
2017
Q1 | $46.4M | Sell |
|
|||||
|
2016
Q4 | $259M | Sell |
|
|||||
|
2016
Q3 | $393M | Buy |
|
|||||
|
2016
Q2 | $93.3M | Buy |
|
|||||
|
2016
Q1 | $12.3M | Sell |
|
|||||
|
2015
Q4 | $175M | Buy |
|
|||||
|
2015
Q3 | $87.3M | Buy |
|
|||||
|
2015
Q2 | $37.7M | Buy |
|
|||||
|
2015
Q1 | $6.06M | Sell |
|
|||||
|
2014
Q4 | $17M | Sell |
|
|||||
|
2014
Q3 | $25.3M | Sell |
|
|||||
|
2014
Q2 | $57.2M | Buy |
|
|||||
|
2014
Q1 | $58.1M | Buy |
|
|||||
|
2013
Q4 | $5.6M | Sell |
|
|||||
|
2013
Q3 | $5.03M | Sell |
|
|||||
|
2013
Q2 | $8.54M | Buy |
|